 |
Receive an email when new publications or events of interest to you become available |
|
David Canter
|
|
David Canter
Director of Healthcare Research
|
|
724 East University Ave.,
Wyly Hall, 1st Floor
Ann Arbor, MI 48109
|
|
phone
|
|
|
fax
|
+1 734.763.5850
|
|
|
|
| |
|
|
| |
David Canter joined the staff of the William Davidson Institute (WDI) in December 2008 as the Director of Healthcare Research. Dr. Canter will lead a new initiative studying how healthcare related businesses evolve in developing countries and what factors hinder or help their development. This work will partner with companies, government agencies, universities and NGOs in the healthcare arena to study how public policy and the actions of private companies and organizations influence the dependence of a country on foreign aid for healthcare, and the impact on businesses supporting health systems. Carrying on work started in Rwanda, Dr. Canter will also generate research on how management skills can be better developed and measured in healthcare workers.
Prior to this appointment at WDI, Dr. Canter was a Senior VP in Pfizer Global Research and Development, and Director of the Michigan Laboratories in Ann Arbor and Kalamazoo. His career covered cardiovascular clinical research, drug development and management of R&D facilities first in Paris and then in Michigan. Dr Canter was responsible for the development of several marketed medicines; the most notable is Lipitor (atorvastatin) which has been the world’s top-selling drug since 2001.
Dr. Canter recently spent six months in Rwanda as a Pfizer Global Health Fellow working with Columbia University’s Access Project based in Kigali.
Dr Canter is a Fellow of the Royal College of Surgeons of London, and a Member of the Faculty of Pharmaceutical Physicians (UK). He has degrees from Cambridge and Liverpool Universities. |
| |
|
| |
|
| |
Personal Links of Interest
|
|
|